Agoracom: Small Cap Investment - Valeo Pharma Inc. - AGORACOM Small Cap 60: 2022 Is Shaping Up To Be Transformational Year For Valeo Pharma (VPH: CSE)

A revenue-generating, small-cap Canadian pharmaceutical company

Revenue Projected at $150,000,000 by 2025

Reply New Message

Back To Forum List View

AGORACOM-KE

Rank: Administrator [?]

Points: 8960 [?]

Votes: 2 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

AGORACOM Small Cap 60: 2022 Is Shaping Up To Be Transformational Year For Valeo Pharma (VPH: CSE)

posted on Apr 18, 2022 05:53PM

Re: AGORACOM Small Cap 60: 2022 Is Shaping Up To Be Transformational Year For Valeo Pharma (VPH: CSE)